{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:02:56Z","timestamp":1780581776083,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.euroneuro.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T05:12:32Z","timestamp":1653541952000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-1224","authenticated-orcid":false,"given":"Renato","family":"de Filippis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-9442","authenticated-orcid":false,"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-8422","authenticated-orcid":false,"given":"Nazar","family":"Kuzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"De Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.04.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620938595","article-title":"Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future","volume":"11","author":"Alomar","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0002","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/jcm8091351","article-title":"State of art of idiosyncratic drug-induced neutropenia or agranulocytosis, with a focus on biotherapies","volume":"8","author":"Andr\u00e8s","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3315\/jdcr.2008.1016","article-title":"An unusual case of DRESS syndrome","volume":"2","author":"Ben-Ari","year":"2008","journal-title":"J. Dermatol. Case Rep."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0004","first-page":"0","article-title":"Spanish guidelines for diagnosis, management, treatment and prevention of DRESS syndrome","author":"Caba\u00f1as","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0006","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.coi.2012.07.010","article-title":"Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis","volume":"24","author":"Camous","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0007","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/schbul\/sbaa163","article-title":"Exploring a safety signal of antipsychotic-associated pneumonia: a pharmacovigilance-pharmacodynamic study","volume":"47","author":"Cepaityte","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bcp.12474","article-title":"Adverse drug reactions - examples of detection of rare events using databases","volume":"80","author":"Chan","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004714-199706000-00022","article-title":"Cellulitis, eosinophilia, and unilateral pleural effusion associated with clozapine treatment","volume":"17","author":"Chatterjee","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0011","article-title":"A case of clozapine-induced myocarditis in a young patient with bipolar disorder","volume":"2015","author":"Cohen","year":"2015","journal-title":"Case Rep. Cardiol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0012","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PEC.0000000000001188","article-title":"DRESS syndrome: drug reaction with eosinophilia and systemic symptoms","volume":"33","author":"Corneli","year":"2017","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2022.2066078","article-title":"Pharmacovigilance approaches to study rare and very rare side-effects: example of clozapine-related DRESS syndrome","author":"de Filippis","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0014","article-title":"Core clinical manifestations of clozapine-related DRESS syndrome: a network analysis","author":"de Filippis","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17512433.2020.1787831","article-title":"Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"13","author":"de Filippis","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0016","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/02698811211021587","article-title":"Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: a systematic review","volume":"35","author":"de Filippis","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0017","article-title":"Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries","author":"De las Cuevas","year":"2021","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000507638","article-title":"A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology","volume":"89","author":"de Leon","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2022-100773","article-title":"An international clozapine guideline with six personalized titrations for preventing myocarditis and pneumonia","author":"de Leon","year":"2022","journal-title":"Gen. psychiatry Accepted."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/schbul\/sbz093","article-title":"Data from the World Health Organization\u2019s pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions","volume":"46","author":"de Leon","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0021","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels","author":"de Leon","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0022","first-page":"A3620","article-title":"Eosinophilic colitis caused by clozapine","volume":"155","author":"de Raad","year":"2011","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0023","article-title":"Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series","author":"Ertu\u011frul","year":"2021","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0024","series-title":"English MedDRA Version 24.0 [WWW Document]","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0025","unstructured":"European Medicines Agency (EMA), n.d. European Medicines Agency policy on access to EudraVigilance data for medicinal products for human use [WWW Document]. URL https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance\/access-eudravigilance-data"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0026","unstructured":"EuropeanMedicinesAgency, n.d. EudraVigilance [WWW Document]. URL https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0027","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0028","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0269881105047287","article-title":"Clozapine-induced toxic hepatitis with skin rash","volume":"19","author":"Fong","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0029","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/apa.15974","article-title":"Progress, challenges and global approaches to rare diseases","volume":"110","author":"Groft","year":"2021","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/acps.13359","article-title":"A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome","volume":"144","author":"Guinart","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0031","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajp.2017.04.013","article-title":"Clozapine-induced DRESS syndrome with multiple and rare organ involvement","volume":"28","author":"Hassine","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0032","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2019.12.057","article-title":"The diagnostic criteria of DRESS syndrome must be addressed","volume":"82","author":"Heymann","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0033","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S2468-2667(19)30056-8","article-title":"International incidence of psychotic disorders, 2002\u201317: a systematic review and meta-analysis","volume":"4","author":"Jongsma","year":"2019","journal-title":"Lancet Public Heal"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0034","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamapsychiatry.2015.2966","article-title":"The role of clozapine in treatment-resistant schizophrenia","volume":"73","author":"Kane","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.9758\/cpn.2013.11.2.103","article-title":"Eosinophilia, pleural effusion, hepatitis, and jaundice occurring early in clozapine treatment","volume":"11","author":"Kang","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.11.053","article-title":"Comments on: DRESS syndrome","volume":"71","author":"Kardaun","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0037","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0038","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0039","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1176\/appi.ajp.162.7.1386-a","article-title":"Clozapine-induced eosinophilic colitis","volume":"162","author":"Karmacharya","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1445-5994.2006.01300.x","article-title":"Acute onset of ascites with clozapine-induced hepatitis","volume":"37","author":"Luo","year":"2007","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0041","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pde.14044","article-title":"Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature","volume":"37","author":"Metterle","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1346351","article-title":"A rare presentation of clozapine-induced DRESS syndrome","volume":"2018","author":"Moazez","year":"2018","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0043","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/17843286.2020.1767459","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by phenytoin re-exposure: case report and systematic review","volume":"77","author":"Mor\u00e1n-Mari\u00f1os","year":"2022","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0044","first-page":"66","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in children","volume":"90","author":"Mori","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0046","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0047","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MJT.0b013e3181ebb268","article-title":"Delayed onset of clozapine-induced leucopenia","volume":"19","author":"Nongpiur","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0048","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4049\/jimmunol.2000646","article-title":"Characterization of clozapine-responsive human T cells","volume":"205","author":"Ogese","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0049","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/14740338.2020.1796965","article-title":"The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses","volume":"19","author":"Park","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J. allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0051","first-page":"2","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","author":"Picard","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0052","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/1203475419867599","article-title":"HLA-B*58:01 genotyping to prevent cases of DRESS and SJS\/TEN in East Asians treated with allopurinol\u2014a Canadian missed opportunity","volume":"23","author":"Ponzo","year":"2019","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0053","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40264-018-0647-1","article-title":"EudraVigilance medicines safety database: publicly accessible data for research and public health protection","volume":"41","author":"Postigo","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0054","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/ph14070611","article-title":"Cardiac events potentially associated to remdesivir: an analysis from the european spontaneous adverse event reporting system","volume":"14","author":"Rafaniello","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0055","doi-asserted-by":"crossref","first-page":"574.e5","DOI":"10.1016\/j.genhosppsych.2012.07.001","article-title":"Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis","volume":"35","author":"Raveendranathan","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0056","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40264-015-0343-3","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a national analysis of data from 10-year post-marketing surveillance","volume":"38","author":"Renda","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0057","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4088\/JCP.09m05024yel","article-title":"Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls","volume":"71","author":"Ronaldson","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0058","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/a-0586-8983","article-title":"Clozapine-induced DRESS syndrome: a case series from the AMSP multicenter drug safety surveillance project","volume":"52","author":"Sanader","year":"2019","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0059","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1176\/appi.ajp.159.11.1947","article-title":"Sweet's syndrome and polyserositis with clozapine","volume":"159","author":"Schonfeldt-Lecuona","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17512433.2021.1877135","article-title":"An update on the complex relationship between clozapine and pneumonia","volume":"14","author":"Schoretsanitis","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0061","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1192\/bjp.2021.58","article-title":"Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy","volume":"219","author":"Segev","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0062","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0063","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0064","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2017.1270940","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management","author":"Shiohara","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0067","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pds.4774","article-title":"Variation of clinical manifestations according to culprit drugs in DRESS syndrome","volume":"28","author":"Sim","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.04.009_bib0068","first-page":"S512","article-title":"Eosinophilic pleural effusion as a rare adverse effect of clozapine","volume":"33","author":"Simonson","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0069","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0976-500X.162004","article-title":"International conference on harmonization of technical requirements for registration of pharmaceuticals for human use","volume":"6","author":"Singh","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0004867419898760","article-title":"Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy","volume":"54","author":"Siskind","year":"2020","journal-title":"Aust. New Zeal. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0071","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archderm.134.7.874","article-title":"DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome","volume":"134","author":"Sontheimer","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0072","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0074","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamadermatol.2013.6698","article-title":"Prolonged evolution of drug reaction with eosinophilia and systemic symptoms","volume":"150","author":"Tetart","year":"2014","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11126-020-09841-3","article-title":"Clinical utility and safety of slower-than-recommended titration of clozapine for treatment-resistant schizophrenia: a retrospective cohort study","volume":"92","author":"Tsukahara","year":"2021","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0076","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13398","article-title":"Risk factors for Clozapine-induced myocarditis and cardiomyopathy: a systematic review and meta-analysis","author":"Vickers","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0077","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41398-021-01613-2","article-title":"Efficacy and safety of clozapine in psychotic disorders\u2014a systematic quantitative meta-review","volume":"11","author":"Wagner","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0078","unstructured":"Wolff, K., Allen, R., Arturo, J., Saavedra, P., Roh, E., 2018. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, in: Suurmond, D. (Ed.), . McGraw Hill, pp. 564\u2013565."},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0079","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.04.009_bib0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00213-021-05824-9","article-title":"Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?","volume":"238","author":"Zhao","year":"2021","journal-title":"Psychopharmacology"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22001778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22001778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T11:11:10Z","timestamp":1706526670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22001778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":80,"alternative-id":["S0924977X22001778"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.04.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}